BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 11469862)

  • 1. Lateral recognition of a dye hapten by a llama VHH domain.
    Spinelli S; Tegoni M; Frenken L; van Vliet C; Cambillau C
    J Mol Biol; 2001 Aug; 311(1):123-9. PubMed ID: 11469862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure.
    Spinelli S; Desmyter A; Frenken L; Verrips T; Tegoni M; Cambillau C
    FEBS Lett; 2004 Apr; 564(1-2):35-40. PubMed ID: 15094039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama.
    Renisio JG; Pérez J; Czisch M; Guenneugues M; Bornet O; Frenken L; Cambillau C; Darbon H
    Proteins; 2002 Jun; 47(4):546-55. PubMed ID: 12001233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Camelid heavy-chain variable domains provide efficient combining sites to haptens.
    Spinelli S; Frenken LG; Hermans P; Verrips T; Brown K; Tegoni M; Cambillau C
    Biochemistry; 2000 Feb; 39(6):1217-22. PubMed ID: 10684599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop.
    Fanning SW; Horn JR
    Protein Sci; 2011 Jul; 20(7):1196-207. PubMed ID: 21557375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of llama single-domain antibodies against methotrexate, a prototypical hapten.
    Alvarez-Rueda N; Behar G; Ferré V; Pugnière M; Roquet F; Gastinel L; Jacquot C; Aubry J; Baty D; Barbet J; Birklé S
    Mol Immunol; 2007 Mar; 44(7):1680-90. PubMed ID: 17011035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features.
    Harmsen MM; Ruuls RC; Nijman IJ; Niewold TA; Frenken LG; de Geus B
    Mol Immunol; 2000 Aug; 37(10):579-90. PubMed ID: 11163394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global analysis of VHHs framework regions with a structural alphabet.
    Noël F; Malpertuy A; de Brevern AG
    Biochimie; 2016 Dec; 131():11-19. PubMed ID: 27613403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
    Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB
    J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head-to-tail fusions of camelid antibodies can be expressed in planta and bind in rumen fluid.
    Winichayakul S; Pernthaner A; Scott R; Vlaming R; Roberts N
    Biotechnol Appl Biochem; 2009 Jun; 53(Pt 2):111-22. PubMed ID: 18844608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of a human VH: requirements for maintaining a monomeric fragment.
    Dottorini T; Vaughan CK; Walsh MA; LoSurdo P; Sollazzo M
    Biochemistry; 2004 Jan; 43(3):622-8. PubMed ID: 14730966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Llama single domain antibodies as a tool for molecular mimicry.
    Zarebski LM; Urrutia M; Goldbaum FA
    J Mol Biol; 2005 Jun; 349(4):814-24. PubMed ID: 15890359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen.
    Dolk E; van Vliet C; Perez JM; Vriend G; Darbon H; Ferrat G; Cambillau C; Frenken LG; Verrips T
    Proteins; 2005 May; 59(3):555-64. PubMed ID: 15778955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-step procedure of recombinant library construction for the selection of efficiently produced llama VH binders directed against cancer markers.
    Kastelic D; Frković-Grazio S; Baty D; Truan G; Komel R; Pompon D
    J Immunol Methods; 2009 Oct; 350(1-2):54-62. PubMed ID: 19744487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody engineering reveals the important role of J segments in the production efficiency of llama single-domain antibodies in Saccharomyces cerevisiae.
    Gorlani A; Hulsik DL; Adams H; Vriend G; Hermans P; Verrips T
    Protein Eng Des Sel; 2012 Jan; 25(1):39-46. PubMed ID: 22143875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae.
    Frenken LG; van der Linden RH; Hermans PW; Bos JW; Ruuls RC; de Geus B; Verrips CT
    J Biotechnol; 2000 Feb; 78(1):11-21. PubMed ID: 10702907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
    Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
    Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.